Literature DB >> 2165189

The effects of cooling on human saphenous vein reactivity to adrenergic agonists.

C T Harker1, P J Ousley, E J Harris, J M Edwards, L M Taylor, J M Porter.   

Abstract

Human saphenous veins were obtained at surgery and assayed immediately (n = 10). The veins were cut into rings, suspended in organ chambers, and connected to force transducers for the recording of isometric tension. One ring served as control whereas others were treated with the alpha 1-adrenoceptor antagonist prazosin (3 X 10(-7) mol/L), or the alpha 2-adrenoceptor antagonist rauwolscine (10(-7) mol/L). In quiescent rings cooling from 37 degrees C to 24 degrees C had no significant effect. Norepinephrine (10(-8)-10(-5) mol/L) caused concentration-dependent contractions with an EC20 (-log concentration of norepinephrine required to induce contractions 20% of maximal) = 6.97 +/- 0.10. The contractions were inhibited by prazosin (EC20 = 5.89 +/- 0.17, p less than 0.001) and rauwolscine (ED20 = 5.78 +/- 0.11, p less than 0.001). In control rings cooling potentiated contractions evoked at concentrations of norepinephrine below 10(-6) mol/L and inhibited those at higher concentrations. In rings treated with alpha-antagonists cooling depressed the maximal contractile responses. Contractions to the alpha 1-agonist, phenylephrine (10(-7)-10(-4) mol/L), were inhibited by cooling, whereas those to the alpha 2-specific agonist B-HT 920 (10(-7)-10(-4) mol/L) showed a pattern similar to that seen with norepinephrine. The data indicate that the human saphenous vein possesses both alpha 1- and alpha 2-adrenoceptors postjunctionally, and that both contribute to contractile responses. Cold augments saphenous vein reactivity to norepinephrine by an apparent increase in the responsiveness of alpha 2-adrenoceptors to agonists. The relationship between temperature and adrenoceptor responsiveness may be of pivotal importance in defining the mechanism of cold-induced vasospasm.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2165189     DOI: 10.1067/mva.1990.20311

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  8 in total

1.  Local regulation of skin blood flow during cooling involving presynaptic P2 purinoceptors in rats.

Authors:  Tadachika Koganezawa; Tomohisa Ishikawa; Yukiyoshi Fujita; Tomonari Yamashita; Takako Tajima; Masaki Honda; Koichi Nakayama
Journal:  Br J Pharmacol       Date:  2006-05-15       Impact factor: 8.739

Review 2.  Intracellular α(2C)-adrenoceptors: storage depot, stunted development or signaling domain?

Authors:  Maqsood A Chotani; Nicholas A Flavahan
Journal:  Biochim Biophys Acta       Date:  2011-05-14

Review 3.  Clinical pharmacology, physiology and pathophysiology of superficial veins--2.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335

4.  The effect of rapid local cooling on human finger nailfold capillary blood pressure and blood cell velocity.

Authors:  M Hahn; A C Shore
Journal:  J Physiol       Date:  1994-07-01       Impact factor: 5.182

5.  Histamine response and local cooling in the human skin: involvement of H1- and H2-receptors.

Authors:  M Grossmann; M J Jamieson; W Kirch
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

6.  Characterization of postsynaptic alpha-adrenoceptors in the arteries supplying the oviduct.

Authors:  G Costa; M Isla; A García-Pascual; E Jimenez; P Recio; A Labadia; A García-Sacristán
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

7.  Role of alpha2C-adrenoceptors in the reduction of skin blood flow induced by local cooling in mice.

Authors:  M Honda; M Suzuki; K Nakayama; T Ishikawa
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

8.  Noradrenaline modulates smooth muscle activity of the isolated intravesical ureter of the pig through different types of adrenoceptors.

Authors:  M Hernández; D Prieto; U Simonsen; L Rivera; M V Barahona; A García-Sacristán
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.